Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 4
2014 2
2015 2
2017 3
2018 3
2019 7
2020 4
2021 4
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Drug repurposing of mito-atovaquone for cancer treatment.
Villa-Ruano N, Anaya-Ruiz M, Villafaña-Diaz L, Barron-Villaverde D, Perez-Santos M. Villa-Ruano N, et al. Among authors: anaya ruiz m. Pharm Pat Anal. 2023 Jul;12(4):143-149. doi: 10.4155/ppa-2023-0015. Epub 2023 Oct 6. Pharm Pat Anal. 2023. PMID: 37801038
Estrogens as a Possible Therapeutic Strategy for the Management of Neuroinflammation and Neuroprotection in COVID-19.
Bandala C, Cárdenas-Rodríguez N, Reyes-Long S, Cortés-Algara A, Contreras-García IJ, Cruz-Hernández TR, Alfaro-Rodriguez A, Cortes-Altamirano JL, Perez-Santos M, Anaya-Ruiz M, Lara-Padilla E. Bandala C, et al. Among authors: anaya ruiz m. Curr Neuropharmacol. 2023;21(10):2110-2125. doi: 10.2174/1570159X21666230616103850. Curr Neuropharmacol. 2023. PMID: 37326113 Free PMC article.
Treatment of solid tumors using bispecific anti-PDL-1/ICOS antibody.
Perez-Santos M, Anaya-Ruiz M, Sanchez-Esgua G, Villafaña-Diaz L, Barron-Villaverde D. Perez-Santos M, et al. Among authors: anaya ruiz m. Pharm Pat Anal. 2021 Mar;10(2):67-72. doi: 10.4155/ppa-2020-0035. Epub 2021 Apr 8. Pharm Pat Anal. 2021. PMID: 33829869
OX40 agonists for cancer treatment: a patent review.
Cebada J, Perez-Santos M, Bandala C, Lara-Padilla E, Herrera-Camacho I, Rosas-Murrieta NH, Millán-Pérez Peña L, Monjaraz E, Flores A, Anaya-Ruiz M. Cebada J, et al. Among authors: anaya ruiz m. Expert Opin Ther Pat. 2021 Jan;31(1):81-90. doi: 10.1080/13543776.2021.1825688. Epub 2020 Oct 6. Expert Opin Ther Pat. 2021. PMID: 32945223 Review.
[Molecular diagnosis of breast cancer: prognostic and therapeutic implications].
Maycotte P, Medina-Benítez D, Ramírez-Torres N, López-Muñoz E, Mendoza-García AV, Cortés-Hernández P, Anaya-Ruiz M. Maycotte P, et al. Among authors: anaya ruiz m. Rev Med Inst Mex Seguro Soc. 2020 Apr 27;58(Supl 1):S62-S74. doi: 10.24875/RMIMSS.M20000116. Rev Med Inst Mex Seguro Soc. 2020. PMID: 34695317 Spanish.
32 results